Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for Acute Depressive Episodes in Bipolar 1 Disorder
NCT01677182Phase 3Terminated
- Sponsor
- Takeda
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of ramelteon in bipolar I disorder, sponsored by Takeda. Started Aug 2012; status: terminated.
02
Drugs
ramelteon
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01677182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677182.